In humans, mutations in TMPRSS6 lead to a genetic disorder characterized by an iron refractory iron deficiency anemia (IRIDA) that is unresponsive to oral iron treatment but partially responsive to parenteral iron therapy [2]. This evidence concerns the gene TMPRSS6 and IRIDA syndrome.